Search

everythinglearnresearchcommunity

for

Search:↓

Patients chose Chinese herbal medicine for safety, relapse prevention, and as an alternative to conventional treatments, but found preparation burdensome.

A girl with a rare syndrome had successful hair loss treatment with no relapse after 4 years.

A rare type of skin cancer with mucosal involvement was partially treated but eventually relapsed.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

A 5-year-old boy with alopecia totalis had temporary hair regrowth with treatment but relapsed, highlighting the need for thorough investigation and holistic care.

Pulse steroid therapy for alopecia areata shows a 43% complete response rate but has a high relapse rate, especially in children.

DPCP is effective for treating severe alopecia areata, but relapse is common.

Face transplant for a severe autoimmune disease patient was successful, improving appearance and function without disease relapse after three years.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Alopecia areata was most common in people in their 30s and 40s, with some family history and a higher relapse rate, and larger bald areas responded better to specific immunotherapy.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.

Platelet-rich plasma (PRP) is effective in treating various skin conditions and improving hair density, thickness, and patient satisfaction, with lower relapse rates for Alopecia Areata.

Herbal lotions are effective for severe hair loss, with a 64.8% success rate, but relapse is common and long-term management requires allergen control and possible corticosteroid use.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Younger patients and those with more hair loss are less likely to benefit from oral steroid treatment for hair loss, and low vitamin D may predict relapse.

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

A 14-year-old girl with a condition that makes her hair easy to pull out also has a hair-pulling disorder, and treatment helped but she relapsed after a year.

Countries with stricter cultures had fewer COVID-19 cases and deaths, paranoia is linked to false memories, psychosocial intervention works as well with or without antipsychotic drugs for young people with psychosis, smartphones can detect changes in behavior indicating illness relapse, and recruitment agents show regional and gender biases.

The document concludes that low-dose acne treatment is most suitable for moderate acne, with high patient satisfaction and low relapse rates.

PUVA treatment led to significant hair regrowth in over half of the patients with alopecia areata totalis and universalis.

Diphencyprone (DPC) is an effective and safe long-term treatment for alopecia areata, especially with maintenance therapy.

Systemic corticosteroids don't prevent severe alopecia areata from spreading or relapsing.

Alopecia areata in children is usually mild and effectively treated with strong topical steroids.

Low-dose isotretinoin is as effective as conventional doses for acne and has fewer side effects.

Endoscopic forehead and brow lifting safely and consistently improves aged eyebrows, but may have complications.

Longer 3 mm needles were most effective for dog hair regrowth, but hair loss often returned and some dogs felt itchy.

The rash resolved after stopping ponatinib.

Talquetamab may cause hair loss and skin issues.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.